![1-[1-(1-Benzothiophen-2-Yl)Cyclohexyl]-3-(Fluoromethyl)Piperidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFB97817.webp&w=3840&q=75)

1-[1-(1-Benzothiophen-2-Yl)Cyclohexyl]-3-(Fluoromethyl)Piperidine
CAS:
Ref. 3D-FB97817
![1-[1-(1-Benzothiophen-2-Yl)Cyclohexyl]-3-(Fluoromethyl)Piperidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFB97817.webp&w=3840&q=75)

Product Information
Name:1-[1-(1-Benzothiophen-2-Yl)Cyclohexyl]-3-(Fluoromethyl)Piperidine
Brand:Biosynth
Description:1-[1-(1-Benzothiophen-2-Yl)Cyclohexyl]-3-(Fluoromethyl)Piperidine (BZTCHP) is a radiolabeled substrate for the dopamine transporter. It has been used in positron emission tomography studies to monitor dopaminergic nerve terminal degeneration and reuptake in Parkinson's disease patients who have undergone deep brain stimulation surgery. BZTCHP binds to the dopamine transporter, preventing the uptake of dopamine by neurons. This prevents the formation of dopamine from L-DOPA, which is needed for normal motor function. BZTCHP has been shown to be effective in reducing symptoms of hemiparkinsonism when given orally.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:331.49 g/mol
Formula:C20H26FNS
Purity:Min. 95%
InChI:InChI=1S/C20H26FNS/c21-14-16-7-6-12-22(15-16)20(10-4-1-5-11-20)19-13-17-8-2-3-9-18(17)23-19/h2-3,8-9,13,16H,1,4-7,10-12,14-15H2
InChI key:InChIKey=YFHOQGMMEMFUAQ-UHFFFAOYSA-N
SMILES:FCC1CCCN(C2(c3cc4ccccc4s3)CCCCC2)C1